SHAB published 7 Feb 2023 · legal date 19 Jan 2023
Capital increase
Not assessed
Paid in cash
Nominal capital
270’000 → 1’210’609.50
Shares
2’700’000 → 12’106’095
New shares, % of post-step shares
77.7% (9’406’095 new)
Augmentation ordinaire du capital-actions porté de CHF 270'000 à CHF 1'210'609, 50 par l'émission de 6'892'004 actions de CHF 0.10, nominatives, liées selon statuts et entièrement libérées en espèces, et de 2'514'091 actions de CHF 0.10, nominatives, liées selon statuts, entièrement libérées par compensations de créances de 502'818.20. Capital-actions: CHF 1'210'609, 50, entièrement libéré, divisé en 12'106'095 actions de CHF 0.10, nominatives, liées selon statuts.
SHAB published 24 Aug 2023 · legal date 3 Aug 2023
Capital increase
Not assessed
Issued from conditional capital
Nominal capital
1’210’609.50 → 2’102’295.30
Shares
12’743’258 → 21’022’953
New shares, % of post-step shares
39.4% (8’279’695 new)
Augmentation ordinaire du capital-actions porté de CHF 1'210'609, 50 à CHF 2'038'579 par l'émission de 8'279'695 actions de CHF 0.10, nominatives, liées selon statuts. Capital-actions: CHF 2'102'295, 30, entièrement libéré, divisé en 21'022'953 actions de CHF 0.10, nominatives, liées selon statuts.
SHAB published 5 Feb 2024 · legal date 18 Jan 2024
Capital increase
Not assessed
Paid in cash and by other means
Nominal capital
2’124’413.80 → 4’033’415.60
Shares
0 → 19’090’018
New shares, % of post-step shares
100.0% (19’090’018 new)
Capital-actions: CHF 4'033'415, 60, entièrement libéré, divisé en 19'090'018 actions de CHF 0.10 privilégiées quant au produit de liquidation et 21'244'138 actions de CHF 0.10, toutes nominatives, liées selon statuts. L'assemblée générale a introduit une clause statutaire relative à une marge de fluctuation du capital-actions par décision du 18.01.2024; pour les détails, voir les statuts.
Augmentation ordinaire du capital-actions porté de CHF 4'033'415.6 à CHF 4'584'984.4 par l'émission de 5'515'688 actions de CHF 0.10, nominatives, liées selon statuts, privilégiées quant au produit de liquidation. Capital-actions: CHF 4'584'984.4, entièrement libéré, divisé en 24'605'706 actions de CHF 0.10 privilégiées quant au produit de liquidation et 21'244'138 actions de CHF 0.10, toutes nominatives, liées selon statuts. Radiation de la clause statutaire relative à une marge de fluctuation introduite par décision du 18.01.2024.
SHAB published 8 Jan 2025 · legal date 17 Dec 2024
Capital increase
Not assessed
Issued from conditional capital
Nominal capital
4’584’984.40 → 4’684’456.30
Shares
23’610’987 → 24’605’706
New shares, % of post-step shares
4.0% (994’719 new)
Capital-actions: CHF 4'684'456.30, entièrement libéré, divisé en 24'605'706 actions de CHF 0.10 privilégiées quant au produit de liquidation et 22'238'857 actions de CHF 0.10, toutes nominatives, liées selon statuts.
SHAB published 5 Feb 2025 · legal date 23 Jan 2025
Capital increase
Not assessed
Paid in cash
Nominal capital
4’684’456.30 → 5’115’252.50
Shares
24’605’706 → 28’913’668
New shares, % of post-step shares
14.9% (4’307’962 new)
Augmentation ordinaire du capital-actions porté de CHF 4'684'456, 3 à CHF 5'115'252, 5 par l'émission de 4'307'962 actions de CHF 0.10, nominatives, liées selon statuts. Capital-actions: CHF 5'115'252, 5, entièrement libéré, divisé en 28'913'668 actions de CHF 0.10 privilégiées quant au produit de liquidation et 22'238'857 actions de CHF 0.10, toutes nominatives, liées selon statuts.
SHAB published 12 Feb 2025 · legal date 23 Jan 2025
Capital increase
Not assessed
Issued from conditional capital
Nominal capital
5’115’252.50 → 5’116’252.50
Shares
28’903’668 → 28’913’668
New shares, % of post-step shares
0.0% (10’000 new)
Capital-actions: CHF 5'116'252, 5, entièrement libéré, divisé en 28'913'668 actions de CHF 0.10 privilégiées quant au produit de liquidation et 22'248'857 actions de CHF 0.10, toutes nominatives, liées selon statuts.
SHAB published 17 Dec 2025 · legal date 8 Dec 2025
Capital increase
○○○Capital increased
Issued from conditional capital
Nominal capital
5’116’252.50 → 5’210’763
Shares
27’968’563 → 28’913’668
New shares, % of post-step shares
3.3% (945’105 new)
Capital-actions: CHF 5'210'763, entièrement libéré, divisé en 28'913'668 actions de CHF 0.10 privilégiées quant au produit de liquidation et 23'193'962 actions de CHF 0.10, toutes nominatives, liées selon statuts.
From the SHAB entry · French original, person names removed · not an official copy · full entry ↗
The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
The company was founded less than six years before this capital increase.+0.5
The company's purpose describes technology or life-sciences development.+0.5
A new class of preferred shares was created.+1.5
Shares issued out of conditional capital, as when options are exercised.−1.0
Classifier score 0.12 · likely-financing threshold 0.60 · not a calibrated probability
SHAB published 13 Jan 2026 · legal date 22 Dec 2025
Capital increase
●●○Likely financing
Paid in cash
Nominal capital
5’210’763 → 5’367’580.10
Shares
28’913’668 → 30’481’839
New shares, % of post-step shares
5.1% (1’568’171 new)
Augmentation ordinaire du capital-actions porté de CHF 5'210'763 à CHF 5'367'580, 1 par l'émission de 1'568'171 actions de CHF 0.10, privilégiées quant au produit de liquidation. Capital-actions: CHF 5'367'580, 1, entièrement libéré, divisé en 30'481'839 actions de CHF 0.10 privilégiées quant au produit de liquidation et 23'193'962 actions de CHF 0.10, toutes nominatives, liées selon statuts.
From the SHAB entry · French original, person names removed · not an official copy · full entry ↗
The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
The company was founded less than six years before this capital increase.+0.5
The company's purpose describes technology or life-sciences development.+0.5
Classifier score 0.80 · likely-financing threshold 0.60 · not a calibrated probability
SHAB published 25 Feb 2026 · legal date 16 Feb 2026
Capital increase
○○○Capital increased
Issued from conditional capital
Nominal capital
5’367’580.10 → 5’450’301.20
Shares
29’654’628 → 30’481’839
New shares, % of post-step shares
2.7% (827’211 new)
Capital-actions: CHF 5'450'301, 2, entièrement libéré, divisé en 30'481'839 actions de CHF 0.10 privilégiées quant au produit de liquidation et 24'021'173 actions de CHF 0.10, toutes nominatives, liées selon statuts.
From the SHAB entry · French original, person names removed · not an official copy · full entry ↗
The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
The company was founded less than six years before this capital increase.+0.5
The company's purpose describes technology or life-sciences development.+0.5
A new class of preferred shares was created.+1.5
Shares issued out of conditional capital, as when options are exercised.−1.0
Classifier score 0.12 · likely-financing threshold 0.60 · not a calibrated probability
SHAB published 3 Jul 2026 · legal date 19 Jun 2026
Capital increase
○○○Capital increased
Issued from conditional capital
Nominal capital
5’450’301.20 → 5’620’506.40
Shares
54’503’012 → 56’205’064
New shares, % of post-step shares
3.0% (1’702’052 new)
Share classes
25’723’225 × CHF 0.10 · 30’481’839 × CHF 0.10 privilégiées quant au produit de liquidation
Capital-actions: 5'620'506.40, entièrement libéré, divisé en 25'723'225 actions ordinaires de CHF 0.10 et 30'481'839 actions de CHF 0.10, privilégiées quant au produit de liquidation, toutes nominatives, liées selon statuts.
From the SHAB entry · French original, person names removed · not an official copy · full entry ↗
The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
The company was founded less than six years before this capital increase.+0.5
The company's purpose describes technology or life-sciences development.+0.5
A new class of preferred shares was created.+1.5
Shares issued out of conditional capital, as when options are exercised.−1.0
Classifier score 0.15 · likely-financing threshold 0.60 · not a calibrated probability
SHAB published 10 Jul 2026 · legal date 19 Jun 2026
Capital increase
○○○Capital increased
Paid by converting claims
Nominal capital
5’620’506.40 → 5’668’906.70
Shares
30’481’839 → 30’965’842
New shares, % of post-step shares
1.6% (484’003 new)
Capital-actions: CHF 5'668'906, 70, entièrement libéré, divisé en 30'965'842 actions de CHF 0.10 privilégiées quant au produit de liquidation et 25'723'225 actions ordinaires de CHF 0.10, toutes nominatives, liées selon statuts.
From the SHAB entry · French original, person names removed · not an official copy · full entry ↗
The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
The company was founded less than six years before this capital increase.+0.5
The company's purpose describes technology or life-sciences development.+0.5
A new class of preferred shares was created.+1.5
Paid entirely by converting existing claims, with no new money.−1.5
Classifier score 0.20 · likely-financing threshold 0.60 · not a calibrated probability
SHAB published 20 Jul 2026 · legal date 2 Jul 2026
Capital increase
○○○Capital increased
Paid by converting claims
Nominal capital
5’668’906.70 → 5’717’307
Shares
30’965’842 → 31’449’845
New shares, % of post-step shares
1.5% (484’003 new)
Capital-actions: CHF 5'717'307, entièrement libéré, divisé en 31'449'845 actions de CHF 0.10 privilégiées quant au produit de liquidation et 25'723'225 actions ordinaires de CHF 0.10, toutes nominatives, liées selon statuts.
From the SHAB entry · French original, person names removed · not an official copy · full entry ↗
The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
The company was founded less than six years before this capital increase.+0.5
The company's purpose describes technology or life-sciences development.+0.5
A small increment typical of employee share options.−1.0
Paid entirely by converting existing claims, with no new money.−1.5
Classifier score 0.12 · likely-financing threshold 0.60 · not a calibrated probability